Scholarlink

Background <p>Men who have sex with men (MSM), especially those living with HIV, have a high prevalence of HPV infections that might lead to HPV-related diseases, including penile, oropharyngeal and anal carcinomas. Currently, beyond recommendations to get vaccinated during childhood, adult MSM are not included in the German national HPV vaccination recommendation. The aim of this cross-sectional study was to assess knowledge of HPV and HPV vaccination, and further acceptance and uptake of HPV vaccination among MSM in Germany.</p> Methods <p>Participants were recruited between 10/2023 and 07/2024 at 10 German study sites specialized on sexual and/or men’s health. Main inclusion criteria were being MSM, being aged 18–45 years and a German health insurance. Data were obtained through an electronic questionnaire and analyzed descriptively. 20 HPV and 5 HPV vaccination knowledge questions were evaluated using sum scores, with each correct answer scoring 1 point.</p> Results <p>929 participants, aged 18–45 years (median 31), were included in the analysis. 122 (13.1%) were living with HIV and 717 (77.2%) used HIV-PrEP. 731 (78.7%) had prior knowledge of HPV, and 604 (65.0%) were aware of HPV vaccination. Mean sum scores for HPV knowledge (<i>N</i> = 731) and HPV vaccination knowledge questions (<i>N</i> = 604) were 13.3 ± 4.3 and 3.0 ± 1.3, respectively. Among those aware of HPV vaccination, 377 (62.4%) accepted vaccination (defined as already vaccinated (<i>N</i> = 204) or intending to get vaccinated (<i>N</i> = 173), and 223 (36.9%) participants were hesitant. Main reasons for hesitancy included a lack of information and no mandatory reimbursement of adult HPV vaccination costs. For MSM who intended to get vaccinated, payment out of pocket and missing physician recommendations were the main reasons for not being vaccinated yet. Among all analyzed MSM (<i>N</i> = 929), 127 (13.7%) completed a full vaccination schedule (21% within those aware of HPV vaccination).</p> Conclusion <p>Despite almost 80% participants being aware of HPV, vaccination uptake was low among all participants. More information about HPV, i.e., through physicians and social networks, might support informed decision-making. Further, facilitating access by offering reimbursement options for vaccination could potentially be a factor to help increase HPV vaccination uptake among MSM in Germany.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

HPV knowledge and acceptance of HPV vaccination among men who have sex with men (MSM) in Germany: a multicenter, observational, cross-sectional study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月12日

查看全文
  • Cornelia Wähner,
  • Lisa M. Lang,
  • Maher Almahfoud,
  • Daniel Beer,
  • Stefan Esser,
  • Matthias C. Müller,
  • Nils Postel,
  • Anja Potthoff,
  • Stephan Schneeweiß,
  • Sven Schellberg,
  • Agnes Luzak

摘要

Background

Men who have sex with men (MSM), especially those living with HIV, have a high prevalence of HPV infections that might lead to HPV-related diseases, including penile, oropharyngeal and anal carcinomas. Currently, beyond recommendations to get vaccinated during childhood, adult MSM are not included in the German national HPV vaccination recommendation. The aim of this cross-sectional study was to assess knowledge of HPV and HPV vaccination, and further acceptance and uptake of HPV vaccination among MSM in Germany.

Methods

Participants were recruited between 10/2023 and 07/2024 at 10 German study sites specialized on sexual and/or men’s health. Main inclusion criteria were being MSM, being aged 18–45 years and a German health insurance. Data were obtained through an electronic questionnaire and analyzed descriptively. 20 HPV and 5 HPV vaccination knowledge questions were evaluated using sum scores, with each correct answer scoring 1 point.

Results

929 participants, aged 18–45 years (median 31), were included in the analysis. 122 (13.1%) were living with HIV and 717 (77.2%) used HIV-PrEP. 731 (78.7%) had prior knowledge of HPV, and 604 (65.0%) were aware of HPV vaccination. Mean sum scores for HPV knowledge (N = 731) and HPV vaccination knowledge questions (N = 604) were 13.3 ± 4.3 and 3.0 ± 1.3, respectively. Among those aware of HPV vaccination, 377 (62.4%) accepted vaccination (defined as already vaccinated (N = 204) or intending to get vaccinated (N = 173), and 223 (36.9%) participants were hesitant. Main reasons for hesitancy included a lack of information and no mandatory reimbursement of adult HPV vaccination costs. For MSM who intended to get vaccinated, payment out of pocket and missing physician recommendations were the main reasons for not being vaccinated yet. Among all analyzed MSM (N = 929), 127 (13.7%) completed a full vaccination schedule (21% within those aware of HPV vaccination).

Conclusion

Despite almost 80% participants being aware of HPV, vaccination uptake was low among all participants. More information about HPV, i.e., through physicians and social networks, might support informed decision-making. Further, facilitating access by offering reimbursement options for vaccination could potentially be a factor to help increase HPV vaccination uptake among MSM in Germany.